A phase 3 study of the effect of denosumab therapy on bone mineral density in women receiving aromatase inhibitors for non metastatic breast cancer

被引：0
|
作者：
Ellis, G.
Bone, H. G.
Chlebowski, R.
Paul, D.
Spadafora, S.
Smith, J.
Fan, M.
Jun, S.
机构：
[1] Seattle Canc Care Alliance, Seattle, WA USA
[2] Michigan Bone & Mineral Clin, Detroit, MI USA
[3] UCLA Med Ctr, Torrance, CA USA
[4] Rocky Mt Canc Ctr, Denver, CO USA
[5] Algoma Reg Canc Program, Saulte Ste Marie, ON, Canada
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2008年 / 109卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：585 / 586
页数：2
相关论文
共 50 条
  • [41] EFFECT ON BONE MINERAL DENSITY OF ORAL BISPHOSPHONATES IN WOMEN WITH OSTEOPOROSIS AND BREAST CANCER TREATED WITH AROMATASE INHIBITORS: ARE BONE TURNOVER MARKERS USEFUL IN THESE PATIENTS?
    Vazquez, I.
    Casado, E.
    Larrosa, M.
    Dalmau, E.
    Segui, M. A.
    Gratacos, J.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 321 - 321
  • [42] Clinical characteristics of bone fractures in breast cancer women receiving adjuvant aromatase inhibitors
    Wojtacki, J.
    Wiraszka, R.
    Markowicz, A.
    Piotrowska, M.
    EJC SUPPLEMENTS, 2008, 6 (07): : 200 - 201
  • [43] The effect of denosumab in breast cancer patients receiving adjuvant aromatase inhibitors: 36-month results
    Yoshimi Ouchi
    Katsuhiko Nakatsukasa
    Koichi Sakaguchi
    Midori Morita
    Hiroshi Koyama
    Takayuki Matsuda
    Makoto Kato
    Eiichi Konishi
    Hisako Ono
    Tetsuya Taguchi
    Journal of Bone and Mineral Metabolism, 2021, 39 : 224 - 229
  • [44] The effect of denosumab in breast cancer patients receiving adjuvant aromatase inhibitors: 36-month results
    Ouchi, Yoshimi
    Nakatsukasa, Katsuhiko
    Sakaguchi, Koichi
    Morita, Midori
    Koyama, Hiroshi
    Matsuda, Takayuki
    Kato, Makoto
    Konishi, Eiichi
    Ono, Hisako
    Taguchi, Tetsuya
    JOURNAL OF BONE AND MINERAL METABOLISM, 2021, 39 (02) : 224 - 229
  • [45] Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important
    Markopoulos, Christos
    BREAST CANCER RESEARCH, 2010, 12 (04)
  • [46] Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
    Smith, Matthew R.
    Saad, Fred
    Egerdie, Blair
    Szwedowski, Maciej
    Tammela, Teuvo L. J.
    Ke, Chunlei
    Leder, Benjamin Z.
    Goessl, Carsten
    JOURNAL OF UROLOGY, 2009, 182 (06): : 2670 - 2675
  • [47] Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important
    Christos Markopoulos
    Breast Cancer Research, 12
  • [48] Effect of denosumab on bone mineral density (BMD) in women with breast cancer (BC) and men with prostate cancer (PC) undergoing hormone ablation therapy
    Smith, M. R.
    Ellis, G.
    Saad, F.
    Tammela, T.
    Bone, H.
    Egerdie, B.
    Ke, C.
    Jun, S.
    Dansey, R.
    Goessl, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] Bone Mineral Density at the Time of Initiating Aromatase Inhibitor Therapy Is Associated With Decreased Fractures in Women With Breast Cancer
    Lu, Huifang
    Lei, Xiudong
    Zhao, Hui
    Elting, Linda
    Siricilla, Mamatha
    Ursani, Mohammad Ali
    Giordano, Sharon H.
    Suarez-Almazor, Maria
    JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (05) : 861 - 871
  • [50] Aromatase inhibitors and bone health in women with breast cancer
    Chien, Amy Jo
    Goss, Paul E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (33) : 5305 - 5312
12345